The lawsuit revolved around Insulet's Omnipod tubeless insulin pump – used with continuous glucose monitors (CGMs) to create an artificial pancreas system used by diabetics – and claimed that ...

On December 3, 2024, a U.S District Court for the District of Massachusetts jury awarded Plaintiff Insulet Corporation $452 ...

(Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced the Omnipod 5 Automated Insulin Delivery System is now ...

Insulet stock soared out of a buy zone Friday ... third-quarter report follows the international launch of its Omnipod 5 insulin pump. The company also won Food and Drug Administration clearance ...

(Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced plans to release its financial results for the fourth quarter ...

(Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the Omnipod 5 Automated Insulin Delivery System is now ...

Insulet Corporation PODD recently made its Omnipod 5 automated insulin delivery system commercially ... Omnipod 5 is recognized as the number one insulin pump for new pump users in Europe. Omnipod 5 ...

January 13, 2025--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today ...